Optimi Health to Provide MDMA for Alcohol Addiction Research in Israel

March 27, 2024

Cybin Raises $150 Million Via Oversubscribed Private Placement

March 20, 2024

Gilgamesh Receives $14 Million NIDA Grant to Develop Ibogaine Analog for Addiction Treatment

March 16, 2024

Ketamine: Addiction Treatment or Enabler?

March 12, 2024

Cleveland Clinic Launches Psilocybin Trial

March 6, 2024

Fluence Brings Psychedelic Therapy Training to Ukraine

March 6, 2024